31 July 2019
Visiongain has launched a new pharma report Global OTC Pharmaceutical Market Forecast 2019-2029: Cough, Cold and Allergy, Analgesics, Gastrointestinal, Dermatology, Eye Care, Smoking Cessation Aids, Others.
There has been greater liberalisation of OTC marketing approvals and OTC switches. This is being driven by the benefits it offers to many stakeholders: increased revenue for pharma companies, reduced costs for governments, enhanced status for pharmacists and greater choice and availability for consumers. The rising cost of healthcare across the globe and the effects of the economic recession mean that the trend of favouring OTC switching is very likely to continue.
The lead analyst of the report commented "Electronic pharmacy kiosks, self-assessment and diagnostic tools, and home monitoring systems could increasingly help to support safe and effective self-medication with OTC products. These could potentially alleviate concerns by regulatory authorities regarding whether consumers would be able to decide whether OTC treatment is appropriate.
The current global trend is towards liberalisation of OTC advertisement regulation, driven by government enthusiasm for OTC products in a bid to cut healthcare costs. Many companies are trying to communicate directly with consumers through online and other media, bypassing input from medical professionals."
Leading companies featured in the report include AstraZeneca PLC, Bayer AG, Daiichi Sankyo Company, Limited, GlaxoSmithKline PLC, Johnson & Johnson, Mylan N.V., Pfizer, Inc., Proctor & Gamble Company, Reckitt Benckiser Group PLC, Sanofi S.A. and other companies.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 20 7549 9987.
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Although price is still the most important competitive advantage for a biosimilar company, current discount rates are not enough to automatically convince the key stakeholders of a biosimilar’s value.
10 September 2019
The global anti-infective agents market is one that is driven by innovation. This is vital for maintaining the rich pipeline of anti-infective agents seen in the market today.
09 September 2019
Thyroid disease is one of today’s most prevalent hormonal illnesses. Hyperthyroidism, hypothyroidism, and thyroid nodules are the most common thyroid gland disorders.
05 September 2019
Somatostatin was used to diagnose gastrointestinal tract tumors and acromegaly in the clinical environment.